Mode
Text Size
Log in / Sign up

Excessive maternal zinc supplementation may exacerbate fetal copper deficiency in Menkes disease.

Excessive maternal zinc supplementation may exacerbate fetal copper deficiency in Menkes disease.
Photo by Daniel Dan / Unsplash
Key Takeaway
Consider the hypothesis that excessive maternal zinc may worsen copper deficiency in Menkes disease.

This review addresses the potential adverse interaction between excessive maternal zinc supplementation and Menkes disease, a disorder caused by ATP7A dysfunction. The study population consists of fetuses with this specific genetic condition, though the sample size and specific setting were not reported. The primary outcome of interest was fetal copper deficiency, with secondary outcomes including disease severity and onset.

Main results from the review indicate that excessive zinc intake may interfere with copper absorption, potentially leading to deficiency in the fetus. However, exact numerical data regarding incidence rates or severity scores were not reported in the available evidence. The review highlights that no large-scale or disease-specific studies have evaluated this interaction in relation to Menkes disease or neonatal outcomes. Consequently, the main results remain theoretical rather than empirically quantified in this specific context.

Safety and tolerability data were not reported for this specific intervention in this population. The review notes that limited clinical data exist in pregnant women regarding this interaction. The authors emphasize that the current understanding is based on a hypothesis rather than robust clinical trials. Therefore, the safety profile remains uncertain, and discontinuations or serious adverse events have not been documented in the reviewed literature.

Key limitations include the lack of large-scale studies and the reliance on hypothesis-based reasoning due to scarce data. The practice relevance warrants urgent investigation, as current evidence is insufficient to guide definitive clinical management. Clinicians must recognize that extrapolating from general zinc-copper interactions to Menkes disease requires extreme caution. Until more data are available, the potential for harm cannot be ruled out, and the hypothesis of adverse effects should be considered a significant warning rather than a confirmed risk.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundCopper is an essential micronutrient critical for fetal neurodevelopment, haematopoiesis, angiogenesis, and immune function, with maternal transfer—particularly in the third trimester—playing a key role in establishing fetal copper stores. Disruption of this process, due to genetic defects or micronutrient imbalance, can lead to significant neonatal complications.ObjectiveThis review examines the potential role of excessive maternal zinc supplementation as an underrecognized environmental modifier in Menkes disease (MD), an X-linked disorder caused by mutations in the ATP7A copper transporter. We hypothesize that in fetuses with ATP7A dysfunction, elevated maternal zinc intake may further impair copper absorption and placental transfer through competitive antagonism, thereby exacerbating fetal copper deficiency and influencing disease severity or onset.EvidenceLimited clinical data in pregnant women demonstrate that zinc supplementation can reduce maternal and fetal copper levels, supported by consistent findings from animal models and case reports indicating disrupted copper homeostasis. However, no large-scale or disease-specific studies have evaluated this interaction in relation to Menkes disease or neonatal outcomes.ConclusionGiven the widespread use of zinc supplementation, particularly during the COVID-19 era, its impact on fetal copper status in genetically susceptible populations warrants urgent investigation. Targeted retrospective analyses and well-designed prospective studies are needed to validate this hypothesis. A re-evaluation of prenatal micronutrient strategies with emphasis on trace element balance may improve risk stratification and optimize maternal–fetal health outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.